Literature DB >> 23292243

Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation.

A Antar, Z K Otrock, M Kharfan-Dabaja, Z Salem, S Aractingi, M Mohty, A Bazarbachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23292243     DOI： 10.1038/bmt.2012.256

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

Review 1.  Hypomethylating agents after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Guido Kobbe
Journal:  Stem Cell Investig       Date:  2016-11-28

Review 2.  Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Ulrich Germing; Guido Kobbe
Journal:  Int J Hematol       Date:  2017-11-15       Impact factor: 2.490

3.  Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.

Authors:  Charles Craddock; Myriam Labopin; Marie Robin; Juergen Finke; Patrice Chevallier; Ibrahim Yakoub-Agha; Jean Henri Bourhis; Henrik Sengelov; Didier Blaise; Thomas Luft; Michael Hallek; Nicolaus Kröger; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

4.  Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients.

Authors:  Silje Johansen; Hilde Kollsete Gjelberg; Aymen Bushra Ahmed; Øystein Bruserud; Håkon Reikvam
Journal:  Case Rep Oncol Med       Date:  2018-02-28

5.  Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.

Authors:  Kazuya Sato; Nodoka Tsukada; Junki Inamura; Shigetsuna Komatsu; Keisuke Sato; Masayo Yamamoto; Motohiro Shindo; Kentaro Moriichi; Yusuke Mizukami; Mikihiro Fujiya; Yoshihiro Torimoto; Toshikatsu Okumura
Journal:  Case Rep Hematol       Date:  2021-04-21

Review 6.  Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML.

Authors:  Julia-Annabell Georgi; Sebastian Stasik; Martin Bornhäuser; Uwe Platzbecker; Christian Thiede
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

7.  Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma.

Authors:  Haiqiu Zhao; Zhenkun Dong; Dingming Wan; Weijie Cao; Haizhou Xing; Zhenzhen Liu; Jixin Fan; Haiqiong Wang; Runqing Lu; Yinyin Zhang; Qianqian Cheng; Zhongxing Jiang; Fei He; Xinsheng Xie; Rong Guo
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

8.  Post-transplant relapse of therapy-related MDS as gastric myeloid sarcoma: Case report and review of literature.

Authors:  Amy Song; Masoumeh Ghayouri; Farhan Hiya; Mohammad O Hussaini
Journal:  Leuk Res Rep       Date:  2021-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.